Literature DB >> 23991310

Severe intraoperative complications during VATS Lobectomy compared with thoracotomy lobectomy for early stage non-small cell lung cancer.

Chaoyang Liang1, Huanshun Wen, Yongqing Guo, Bin Shi, Yanchu Tian, Zhiyi Song, Deruo Liu.   

Abstract

BACKGROUND: Video-assisted thoracic surgery (VATS) lobectomy has been proved to have shorter hospital stay, less perioperative complications and less pain compared with lobectomy by thoracotomy, but severe intraoperative complications during VATS lobectomy is rare reported. We compared intraoperative safety between VATS lobectomy and lobectomy by thoracotomy.
METHODS: 659 patients with postoperative stage I and IIa non-small cell lung cancer (NSCLC) who underwent lobectomy in China-Japan Friendship Hospital from February 2008 to June 2012 were analyzed retrospectively, in which 277 were performed by thoracotomy, 357 performed by VATS, and 25 performed by VATS converted to open. Outcomes were analyzed to compare the incidence of significant bleeding, with conversion cases were included into VATS group.
RESULTS: Ten severe intraoperative complications were identified in 10 patients (6 in VATS, 4 in open), with no intraoperative deaths. The incidence of severe intraoperative complications was similar between VATS group and thoracotomy group [1.57% (6/382) vs. 1.44% (4/277), P=1.0]. Most severe intraoperative complications were related to the injury of major pulmonary vessels (9/10), and most of these complications occurred during upper lobectomy (8/10). There was no statistically significant difference in blood loss (242.85±220.47 vs. 240.43±144.36, P=0.865), and operative time (198.00±75.24 vs. 208.05±61.97, P=0.061) between the open and VATS groups, respectively, but blood loss and operative time are significant different after elimination of conversion cases (214.34±151.85 vs. 240.43±144.36, P<0.01; 193.24±72.64 vs. 208.05±61.97, P<0.01).
CONCLUSIONS: Our preliminary study demonstrated that the incidence of severe intraoperative complication during VATS lobectomy was low and similar to open lobectomy. The severe intraoperative complications during VATS lobectomy are manageable and the surgeons need to take proper caution in performing VATS lobectomy.

Entities:  

Keywords:  Lung cancer surgery; bleeding; lobectomy; surgery complications

Year:  2013        PMID: 23991310      PMCID: PMC3755690          DOI: 10.3978/j.issn.2072-1439.2013.08.13

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  16 in total

1.  Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications.

Authors:  Raja M Flores; Ugonna Ihekweazu; Joseph Dycoco; Nabil P Rizk; Valerie W Rusch; Manjit S Bains; Robert J Downey; David Finley; Prasad Adusumilli; Inderpal Sarkaria; James Huang; Bernard Park
Journal:  J Thorac Cardiovasc Surg       Date:  2011-10-19       Impact factor: 5.209

2.  Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.

Authors:  Walter J Scott; Mark S Allen; Gail Darling; Bryan Meyers; Paul A Decker; Joe B Putnam; Robert W McKenna; Rodney J Landrenau; David R Jones; Richard I Inculet; Richard A Malthaner
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02-20       Impact factor: 5.209

3.  A meta-analysis of unmatched and matched patients comparing video-assisted thoracoscopic lobectomy and conventional open lobectomy.

Authors:  Christopher Cao; Con Manganas; Su C Ang; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2012-05

4.  Pulmonary artery bleeding caused during VATS lobectomy.

Authors:  Joel Dunning; William S Walker
Journal:  Ann Cardiothorac Surg       Date:  2012-05

5.  Learning curve associated with VATS lobectomy.

Authors:  René H Petersen; Henrik J Hansen
Journal:  Ann Cardiothorac Surg       Date:  2012-05

6.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.

Authors:  Subroto Paul; Nasser K Altorki; Shubin Sheng; Paul C Lee; David H Harpole; Mark W Onaitis; Brendon M Stiles; Jeffrey L Port; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

7.  Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer.

Authors:  Raja M Flores; Ugonna N Ihekweazu; Nabil Rizk; Joseph Dycoco; Manjit S Bains; Robert J Downey; Prasad Adusumilli; David J Finley; James Huang; Valerie W Rusch; Inderpal Sarkaria; Bernard Park
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11-05       Impact factor: 5.209

8.  Thoracoscopic lobectomy: the gold standard for early-stage lung cancer?

Authors:  Matthew G Hartwig; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

9.  Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer.

Authors:  Raja M Flores; Bernard J Park; Joseph Dycoco; Anna Aronova; Yael Hirth; Nabil P Rizk; Manjit Bains; Robert J Downey; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07       Impact factor: 5.209

10.  Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors.

Authors:  Daniel J Boffa; Mark S Allen; Joshua D Grab; Henning A Gaissert; David H Harpole; Cameron D Wright
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12-21       Impact factor: 5.209

View more
  8 in total

1.  The end of robot-assisted laparoscopy? A critical appraisal of scientific evidence on the use of robot-assisted laparoscopic surgery.

Authors:  Jeroen Heemskerk; Nicole D Bouvy; Cor G M I Baeten
Journal:  Surg Endosc       Date:  2014-04       Impact factor: 4.584

2.  A comparative analysis of lung cancer patients treated with lobectomy via three-dimensional video-assisted thoracoscopic surgery versus two-dimensional resection.

Authors:  Chengliang Yang; Lili Mo; Yegang Ma; Guilin Peng; Yi Ren; Wei Wang; Yongyu Liu; Jianxing He
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 3.  Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS).

Authors:  Dingpei Han; Yuqin Cao; Han Wu; Haifeng Wang; Lei Jiang; Deping Zhao; Feng Yao; Shuben Li; Chong Zhang; Bin Zheng; Junqiang Fan; Yongde Liao; Bin Qiu; Fengwei Tan; Chun Chen; Yuming Zhu; Shugeng Gao; Hecheng Li
Journal:  Transl Lung Cancer Res       Date:  2020-08

4.  Video-assisted thoracoscopic surgery versus open thoracotomy in the management of empyema: A comparative study.

Authors:  Rohit Jindal; Amandeep Singh Nar; Atul Mishra; Ravinder Pal Singh; Aayushi Aggarwal; Namita Bansal
Journal:  J Minim Access Surg       Date:  2021 Oct-Dec       Impact factor: 1.407

5.  Algorithm-based troubleshooting to manage bleeding during thoracoscopic anatomic pulmonary resection.

Authors:  Hitoshi Igai; Mitsuhiro Kamiyoshihara; Ryohei Yoshikawa; Fumi Ohsawa; Tomohiro Yazawa; Natsumi Matsuura
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

6.  Risk factors for major adverse events of video-assisted thoracic surgery lobectomy for lung cancer.

Authors:  Jie Yang; Yan Xia; Yang Yang; Zheng-Zheng Ni; Wen-Xin He; Hai-Feng Wang; Xiao-Xiong Xu; Yu-Ling Yang; Ke Fei; Ge-Ning Jiang
Journal:  Int J Med Sci       Date:  2014-06-11       Impact factor: 3.738

7.  Inadvertently transected left superior pulmonary vein during thoracoscopic left lower lobectomy.

Authors:  Yangki Seok; Eungbae Lee
Journal:  J Cardiothorac Surg       Date:  2016-05-26       Impact factor: 1.637

8.  Comparative study of three-dimensional versus two-dimensional video-assisted thoracoscopic two-port lobectomy.

Authors:  Peng Jiao; Qing-Jun Wu; Yao-Guang Sun; Chao Ma; Wen-Xin Tian; Han-Bo Yu; Hong-Feng Tong
Journal:  Thorac Cancer       Date:  2016-10-04       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.